Finance

Lists
524703:BOM
Sandu Pharmaceuticals Ltd
₹35,50
+1,43%
(+0,50) 1D
15 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524703...
Open
₹35,02
High
₹35,80
Low
₹35,01
Mkt. cap
342,97 m
Avg. vol.
2,30 k
Volume
1,21 k
Dividend
2,82%
Quarterly dividend
₹0,25
Ex-dividend date
04 Sep. 2026
P/E ratio
18,06
52-wk high
₹50,00
52-wk low
₹30,00
EPS
₹1,97
No. of employees
258
Open
₹35,02
High
₹35,80
Low
₹35,01
Mkt. cap
342,97 m
Avg. vol.
2,30 k
Volume
1,21 k
Dividend
2,82%
Quarterly dividend
₹0,25
Ex-dividend date
04 Sep. 2026
P/E ratio
18,06
52-wk high
₹50,00
52-wk low
₹30,00
EPS
₹1,97
No. of employees
258
News stories
From web sources and news partners
About Sandu Pharmaceuticals Ltd
CEO-
Employees258
Founded1899
Headquarters-
SectorPersonal care products
Websitesandu.in
Last report
11 Aug. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
163,89 m / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
176,21 m
187,61 m
168,53 m
163,89 m
Cost of goods sold
83,27 m
78,87 m
85,77 m
65,40 m
Cost of revenue
83,27 m
78,87 m
85,77 m
65,40 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26,38 m
26,46 m
122,83 m
27,94 m
Operating expense
86,01 m
99,99 m
78,68 m
94,76 m
Total operating expenses
169,28 m
178,86 m
164,46 m
160,16 m
Operating income
6,93 m
8,75 m
4,08 m
3,73 m
Other non operating income
480,00 k
137,00 k
-837,00 k
174,00 k
EBT including unusual items
7,15 m
8,55 m
7,47 m
3,60 m
EBT excluding unusual items
7,15 m
8,55 m
7,47 m
3,60 m
Income tax expense
1,90 m
-1,20 m
7,04 m
1,32 m
Effective tax rate
26,63%
-14,05%
94,18%
36,70%
Other operating expenses
57,94 m
71,87 m
-45,80 m
65,18 m
Net income
5,24 m
9,75 m
435,00 k
2,28 m
Net profit margin
2,98%
5,20%
0,26%
1,39%
Earnings per share
-
-
-
-
Interest and investment income
-
-
4,44 m
-
Interest expense
-266,00 k
-335,00 k
-212,00 k
-299,00 k
Net interest expenses
-266,00 k
-335,00 k
4,23 m
-299,00 k
Depreciation and amortization charges
1,69 m
1,66 m
1,65 m
1,64 m
EBITDA
8,66 m
9,86 m
5,18 m
5,42 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme